Spots Global Cancer Trial Database for Biomarkers Study in Pancreatic Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Biomarkers Study in Pancreatic Cancer
Official Title: Biomarkers Study in Pancreatic Cancer
Study ID: NCT01666184
Conditions
Interventions
Study Description
Brief Summary: Study Design: Patients are eligible if (1) enrolled to TCOG 3207(2) received surgery or biopsy for pancreatic cancer; (3) willing to sign informed consent. The pancreatic tumor, tissue specimen and blood sample before or after treatment will be collected from department of pathology, surgery or diagnostic medicine.
Detailed Description: We expect to collect tissue samples from 270 pancreatic cancer patients of any stages. Since the enrollment criteria are not limited to new patients, we expect to enroll 67 patients a year. The patient enrollment will be completed in 4 years. Clinical follow-up will be completed in another one year. Data analysis and correlation study may be finished in the end of 5th year of this study.
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Yi-Ming Shyr, M.D.
Affiliation: Taipei Veterans General Hospital, Taiwan
Role: PRINCIPAL_INVESTIGATOR
Name: Tsann-Long Hwang, M.D.
Affiliation: Chang Gung Memorial Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Ruey-Kuen Hsieh, M.D.
Affiliation: Mackay Memorial Hospital Taipei, Taiwan
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
